The findings come on the heels of the US Food and Drug Administration approving the Harmony system (Medtronic) in March as the first nonsurgical heart valve to treat pulmonary valve regurgitation in ...

TWO patients seen recently at the University of Texas Medical Branch Hospitals presented severe chronic pulmonary insufficiency and hypercapnia complicated by systemic alkalosis. The alkalosis was ...

Please provide your email address to receive an email when new articles are posted on . New data published in Chest support a lower tricuspid regurgitation velocity of 2.7 m per second for pulmonary ...

RAPID advances in surgery have made an understanding of the significance of any potentially correctable valvular defect as important as the ability to establish an exact diagnosis. As an isolated ...

The US Food and Drug Administration (FDA) has approved Medtronic's Harmony Transcatheter Pulmonary Valve (TPV) System to treat severe pulmonary regurgitation in pediatric and adult patients who have a ...

Moderate/severe tricuspid regurgitation in PAH patients is linked to worse survival, especially with preserved TAPSE or low-risk TAPSE/sPAP ratios. The study emphasizes the prognostic value of ...

A study of one year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR) was ...

Edwards Lifesciences is closing out 2021 by nabbing a new approval from FDA. The Irvine, CA-based company said it won the nod for the use of the Edwards Sapien 3 transcatheter valve with the Alterra ...

Longer-term clinical and hemodynamic outcomes are generally positive following transcatheter pulmonary valve replacement with the Melody valve, according to a study published online May 5, 2015, ahead ...